A new way to look at liver cancer

Hepatology

Volumn 40, Issue 3, 2004, Pages 521-523

  Locker, Joseph ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER GRADING; CANCER RISK; CLINICAL FEATURE; CONFOCAL LASER MICROSCOPY; DISEASE COURSE; EDITORIAL; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; MEDICAL GENETICS; MEDICAL LITERATURE; PATHOLOGIST; PRIORITY JOURNAL; PUBLICATION; RISK FACTOR; CLASSIFICATION; GENETICS; LIVER TUMOR; MORTALITY; NOTE;

CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION PROFILING; HUMANS; LIVER NEOPLASMS;

EID: 4544382509     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20368     Document Type: Editorial

References (24)

1. Lee J-S, Chu I-S, Heo J, Calvisi DR, Sun Z, Roskams T, et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. HEPATOLOGY 2004;40:667-676.
2. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000;24:227-235.
3. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature 2000;406:747-752.
4. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-536.
5. Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T, Okada T, et al. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res 2002;62:3939-3944.
6. Iizuka N, Oka M, Yamada-Okabe H, Nishida M, Maeda Y, Mori N, et al. Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet 2003;361:923-929.
7. Iizuka N, Oka M, Yamada-Okabe H, Hamada K, Nakayama H, Mori N, et al. Molecular signature in three types of hepatocellular carcinoma with different viral origin by oligonucleotide microarray. Int J Oncol 2004;24:565-574.
8. Okada T, Iizuka N, Yamada-Okabe H, Mori N, Tamesa T, Takemoto N, et al. Gene expression profile linked to p53 status in hepatitis C virus-related hepatocellular carcinoma. FEBS Lett 2003;555:583-590.
9. Ye QH, Qin LX, Forgues M, He P, Kim JW, Peng AC, et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 2003;9:416-423.
10. Poellinger L, Johnson RS. HIF-1 and hypoxic response: the plot thickens. Curr Opin Genet Dev 2004;14:81-85.
11. CLIP-Investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. HEPATOLOGY 1998;28:751-755.
12. Ito Y, Matsuura N, Sakon M, Takeda T, Umeshita K, Nagano H, et al. Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma. Br J Cancer 1999;81:747-751.
13. Liu S, Edgerton SM, Moore DH 2nd, Thor AD. Measures of cell turnover (proliferation and apoptosis) and their association with survival in breast cancer. Clin Cancer Res 2001;7:1716-1723.
14. Nagai H, Terada Y, Tajiri T, Yabe A, Onda M, Nagahata T, et al. Characterization of liver-cirrhosis nodules by analysis of gene-expression profiles and patterns of allelic loss. J Hum Genet 2004;49:246-255.
15. Chen X, Cheung ST, So S, Fan ST, Barry C, Higgins J, et al. Gene expression patterns in human liver cancers. Mol Biol Cell 2002;13:1929-1939.
16. Cheung ST, Chen X, Guan XY, Wong SY, Tai LS, Ng IO, et al. Identify metastasis-associated genes in hepatocellular carcinoma through clonality delineation for multinodular tumor. Cancer Res 2002;62:4711-4721.
17. Hu L, Lau SH, Tzang CH, Wen JM, Wang W, Xie D, et al. Association of Vimentin overexpression and hepatocellular carcinoma metastasis. Oncogene 2004;23:298-302.
18. Aizaki H, Harada T, Otsuka M, Seki N, Matsuda M, Li YW, et al. Expression profiling of liver cell lines expressing entire or parts of hepatitis C virus open reading frame. HEPATOLOGY 2002;36:1431-1438.
19. Anders RA, Yerian LM, Tretiakova M, Davison JM, Quigg RJ, Domer PH, et al. cDNA microarray analysis of macroregenerative and dysplastic nodules in end-stage hepatitis C virus-induced cirrhosis. Am J Pathol 2003;162:991-1000.
20. Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T, Okada T, et al. Differential gene expression in distinct virologic types of hepatocellular carcinoma: association with liver cirrhosis. Oncogene 2003;22:3007-3014.
21. Okabe H, Satoh S, Kato T, Kitahara O, Yanagawa R, Yamaoka Y, et al. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: Identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 2001;61:2129-2137.
22. Smith MW, Yue ZN, Geiss GK, Sadovnikova NY, Carter VS, Boix L, et al. Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma. Cancer Res 2003;63:859-864.
23. Hoshida Y, Moriyama M, Otsuka M, Kato N, Goto T, Taniguchi H, et al. Identification of genes associated with sensitivity to 5-fluorouracil and cisplatin in hepatoma cells. J Gastroenterol 2002;37(Suppl l4):92-95.
24. Moriyama M, Hoshida Y, Otsuka M, Nishimura S, Kato N, Goto T, et al. Relevance network between chemosensitivity and transcriptome in human hepatoma cells. Mol Cancer Ther 2003;2:199-205.